Overview

Controlled Sedation for Cataract Surgery

Status:
Terminated
Trial end date:
2016-01-30
Target enrollment:
Participant gender:
Summary
This study evaluates the surgeon and patient´s satisfaction who undergoes cataract surgery using either dexmedetomidine or remifentanil as sedation
Phase:
Phase 4
Details
Lead Sponsor:
Fundación Universitaria de Ciencias de la Salud
Treatments:
Dexmedetomidine
Remifentanil